Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

XTMAB-16 is an anti-TNFa monoclonal antibody currently under investigation. Based on its ability to block TNFa, XTMAB-16 may disrupt an inflammatory pathway and help slow granuloma formation.

The study will be presented on Monday, May 19, highlighting key advancements in Xentria's investigational monoclonal antibody therapy for pulmonary sarcoidosis. Further demonstrating its ...

Lupus pernio: common in African American women, represents chronic sarcoidosis, indurated plaques, and discoloration of nose, cheeks, lips and ears; nasal mucosa often involved, associated with ...